Abstract
Therapy that targets disease-causing mutations could become the first of its kind approved for use in the United States.
Cite
CITATION STYLE
APA
Ledford, H. (2017). FDA advisers back gene therapy for rare form of blindness. Nature, 550(7676), 314–314. https://doi.org/10.1038/nature.2017.22819
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free